Xellia Pharmaceuticals, a specialty pharmaceutical company providing anti-infective treatments, has expanded its Raleigh, NC site to enable the relocation of its North American headquarters from Grayslake, IL. One year removed from its acquisition of the Raleigh plant from Fresenius Kabi, Xellia has taken on new premises adjacent to its dedicated lyophilized (free-dried) vial manufacturing facility. The result is the combination of the company’s North American commercial function with the man...